Skip Nav Destination
The Blood Cancer Discovery editors proudly present this collection of impactful myeloma articles that have been published in the Journal.
-
Recommendations on Eliminating Racial Disparities in Multiple Myeloma Therapies: A Step toward Achieving Equity in Healthcare
. -
Determinants of Response and Mechanisms of Resistance of CAR T-cell Therapy in Multiple Myeloma
. -
Dual Targeting with CAR T Cells to Limit Antigen Escape in Multiple Myeloma
. -
Don't Compromise Myeloma Care Due to COVID-19 Pandemic!
. -
Finding the Optimal Partner to Pair with Bispecific Antibody Therapy for Multiple Myeloma
. -
Bortezomib Induces Immunogenic Cell Death in Multiple Myeloma
. -
Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape–Driven Relapse in Multiple Myeloma
. -
Monosomic Loss of MIR15A/MIR16-1 Is a Driver of Multiple Myeloma Proliferation and Disease Progression
. -
COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers
. -
Revealing the Impact of Structural Variants in Multiple Myeloma
. -
Bortezomib Induces Anti–Multiple Myeloma Immune Response Mediated by cGAS/STING Pathway Activation
. -
Lysine Demethylase 5A is Required for MYC Driven Transcription in Multiple Myeloma
. -
ROBO1 Promotes Homing, Dissemination, and Survival of Multiple Myeloma within the Bone Marrow Microenvironment
. -
Tumor Burden Limits Bispecific Antibody Efficacy through T-cell Exhaustion Averted by Concurrent Cytotoxic Therapy
.
RSS Feeds